Described herein are indolyl or indolinyl hydroxamates and pharmaceutical compositions comprising the same, which show histone diacetylase (HDAC) inhibition activity. Also disc a method for treating cancer with these compounds.Linvention concerne des composés dindolyle ou dindolinyle. Elle divulgue aussi un procédé de traitement du cancer avec ces composés.